Literature DB >> 16985691

Modern brachytherapy for localized prostate cancers: the northwest hospital (Seattle) experience.

L J Korb, M K Brawer.   

Abstract

Modern ultrasound-guided prostate brachytherapy is rapidly changing the way localized prostate cancer is managed. With routine use of prostate-specific antigen screening, prostate cancer is being diagnosed in younger men, who are understandably concerned about the morbidity of radical treatments that may significantly decrease their quality of life. Numerous studies of prostate brachytherapy have shown the excellent disease control rates achieved while maintaining low levels of urinary and erectile difficulties. This report examines a modern implant method of brachytherapy; describes patient selection for brachytherapy, alone and in combination with external beam therapy; and presents results from a series of men followed for 12 years.

Entities:  

Year:  2001        PMID: 16985691      PMCID: PMC1476032     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  27 in total

1.  Transperineal ultrasound-guided implantation of the prostate: morbidity and complications.

Authors:  J C Blasko; H Ragde; P D Grimm
Journal:  Scand J Urol Nephrol Suppl       Date:  1991

2.  Retropubic implantation to iodine 125 in the treatment of prostatic cancer.

Authors:  W F Whitmore; B Hilaris; H Grabstald
Journal:  J Urol       Date:  1972-12       Impact factor: 7.450

3.  Present status of interstitial irradiation in managing prostatic cancer.

Authors:  R H Flocks
Journal:  JAMA       Date:  1969-10-13       Impact factor: 56.272

4.  Treatment of carcinoma of the prostate by cobalt-beam therapy.

Authors:  J E Bennett
Journal:  Radiology       Date:  1968-03       Impact factor: 11.105

5.  Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography.

Authors:  H H Holm; N Juul; J F Pedersen; H Hansen; I Strøyer
Journal:  J Urol       Date:  1983-08       Impact factor: 7.450

6.  Radiotherapy in the conservative treatment of operable and locally inoperable carcinoma of the prostate.

Authors:  J A Del Regato
Journal:  Radiology       Date:  1967-04       Impact factor: 11.105

7.  High 10-year survival rate in patients with early, untreated prostatic cancer.

Authors:  J E Johansson; H O Adami; S O Andersson; R Bergström; L Holmberg; U B Krusemo
Journal:  JAMA       Date:  1992 Apr 22-29       Impact factor: 56.272

8.  Erectile functioning of men treated for prostate carcinoma.

Authors:  J W Robinson; M S Dufour; T S Fung
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

9.  Radical perineal prostatectomy for palpable, clinically localized, non-obstructive cancer: experience at the Johns Hopkins Hospital 1909-1963.

Authors:  H J Jewett
Journal:  J Urol       Date:  1980-10       Impact factor: 7.450

10.  Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer.

Authors:  R G Stock; N N Stone; C Iannuzzi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-05-01       Impact factor: 7.038

View more
  3 in total

1.  Management of clinically localized prostate cancer.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2004

2.  A novel greedy heuristic-based approach to intraoperative planning for permanent prostate brachytherapy.

Authors:  Bin Liang; Fugen Zhou; Bo Liu; Junjie Wang; Yong Xu
Journal:  J Appl Clin Med Phys       Date:  2015-01-08       Impact factor: 2.102

3.  Thirty-day hospital revisits after prostate brachytherapy: who is at risk?

Authors:  Belinda Li; Eric J Kirshenbaum; Robert H Blackwell; William S Gange; Jennifer Saluk; Matthew A C Zapf; Anai N Kothari; Robert C Flanigan; Gopal N Gupta
Journal:  Prostate Int       Date:  2018-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.